Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06005675 · ClinicalTrials.gov registry record
User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOL
A clinical trial, sponsored by Johnson & Johnson Surgical Vision.
- Completed
- Registry status
- 44
- Enrollment target
NCT06005675: Completed study, sponsored by Johnson & Johnson Surgical Vision.
NCT06005675 is a clinical trial that has completed, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06005675 has completed, sponsored by Johnson & Johnson Surgical Vision.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
Prospective collection of data from medical records, multicenter, post-market clinical follow-up study.
Primary Outcome
Visual Acuity will be collected via observed case data in units of logMAR.
Interventions
- DEVICE Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-09-06 |
| Est. Completion | 2024-05-01 |
What the finished NCT06005675 record still lists
NCT06005675 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Intervention is the first listed.
NCT06005675 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06005675 about?
NCT06005675 is a clinical study titled "User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOL". Prospective collection of data from medical records, multicenter, post-market clinical follow-up study.
What is the current status of trial NCT06005675?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2023-09-06. Estimated completion is 2024-05-01.
What interventions are being tested in trial NCT06005675?
The interventions under investigation include: Intervention (DEVICE).
Who is sponsoring clinical trial NCT06005675?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI